StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Estimated Intangible Amortization — Thereafter by Year

Estimated Intangible Amortization — Thereafter ($M) ($M)

BeOne Medicines Estimated Intangible Amortization — Thereafter: $31.2M in FY2025, up 13.9% from a year earlier.

Latest, FY2025
31.2
Period ended Dec 31, 2025
Change on a year earlier
+13.9%
27.4 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Intangible Assets Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstimated Intangible Amortization — Thereafter ($M) ($M)Year on yearSource
FY2025Dec 31, 202531.2+13.9%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202427.4-16.0%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 202332.6+53.1%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 202221.3-19.3%Form 10-K (filed 2023-02-27) ↗
FY2021Dec 31, 202126.4+2,100.0%Form 10-K (filed 2022-02-28) ↗
FY2020Dec 31, 20201.20-40.0%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 20192-28.6%Form 10-K (filed 2020-03-02) ↗
FY2018Dec 31, 20182.80-20.0%Form 10-K (filed 2019-02-28) ↗
FY2017Dec 31, 20173.50–Form 10-K (filed 2018-02-28) ↗

Cite this data

StockData. (2026). BeOne Medicines Estimated Intangible Amortization — Thereafter ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/intang-sched-after

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.